(Q46226044)

20 December 2017

title

APOBEC3G and HIV-1: strike and counterstrike (English)

1 reference

20 December 2017

author name string

Vanessa B Soros

series ordinal

1

1 reference

20 December 2017

Warner C Greene

series ordinal

2

1 reference

20 December 2017

publication date

1 June 2006

1 reference

20 December 2017

Current infectious disease reports

published in

1 reference

20 December 2017

volume

8

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

317-323

1 reference

20 December 2017

Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-006-0077-6

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

21 January 2018

1 reference

12 December 2020

Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases

1 reference

12 December 2020

Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G

1 reference

12 December 2020

Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".

1 reference

12 December 2020

An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein

1 reference

12 December 2020

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

1 reference

12 December 2020

Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.

1 reference

12 December 2020

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

1 reference

12 December 2020

Nucleotide composition as a driving force in the evolution of retroviruses.

1 reference

12 December 2020

A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis

1 reference

12 December 2020

Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes

1 reference

12 December 2020

APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast

1 reference

12 December 2020

Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases

1 reference

12 December 2020

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

1 reference

12 December 2020

APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia

1 reference

12 December 2020

Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation

1 reference

12 December 2020

APOBEC3G targets human T-cell leukemia virus type 1.

1 reference

12 December 2020

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells

1 reference

12 December 2020

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

1 reference

12 December 2020

Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation

1 reference

12 December 2020

A new type of G-->A hypermutation affecting human immunodeficiency virus

1 reference

12 December 2020

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

1 reference

12 December 2020

Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation

1 reference

12 December 2020

APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.

1 reference

12 December 2020

Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort

1 reference

12 December 2020

Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1

1 reference

12 December 2020

Lentiviral vectors and antiretroviral intrinsic immunity

1 reference

12 December 2020

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

12 December 2020

APOBEC3G genetic variants and their influence on the progression to AIDS.

1 reference

12 December 2020

APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle

1 reference

12 December 2020

Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.

1 reference

12 December 2020

Mammalian retroelements.

1 reference

12 December 2020

Inhibition of hepatitis B virus replication by APOBEC3G.

1 reference

12 December 2020

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo

1 reference

12 December 2020

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

1 reference

12 December 2020

The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins

1 reference

12 December 2020

APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

1 reference

12 December 2020

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

1 reference

12 December 2020

Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases

1 reference

12 December 2020

Complementary function of the two catalytic domains of APOBEC3G.

1 reference

12 December 2020

APOBEC-mediated interference with hepadnavirus production

1 reference

12 December 2020

Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells

1 reference

12 December 2020

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

1 reference

12 December 2020

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

1 reference

12 December 2020

Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection.

1 reference

12 December 2020

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

12 December 2020

G to A hypermutation of hepatitis B virus.

1 reference

12 December 2020

Rapid evolution of primate antiviral enzyme APOBEC3G.

1 reference

12 December 2020

Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.

1 reference

12 December 2020

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

1 reference

12 December 2020

The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay

1 reference

12 December 2020

Evidence for a newly discovered cellular anti-HIV-1 phenotype

1 reference

12 December 2020

10.1007/S11908-006-0077-6

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017